• Health

Eli Lilly’s Alzheimer’s Drug Gains Unanimous FDA Panel Backing

Key Takeaways The FDA advisory panel unanimously endorsed donanemab, Eli Lilly’s monoclonal antibody drug for early-stage Alzheimer’s disease.Clinical trials showed…

• Health

FDA Advisors Shot Down MDMA as Treatment for PTSD. What Went Wrong?

  Key Takeaways An FDA advisory panel concluded that while a novel MDMA-assisted therapy for PTSD is promising, it still…

• Videos

FDA approves recent weight reduction pill